CME Group Stock - Keefe Bruyette & Woods lifts rating to Outperform
19.06.2026 - 16:19:17 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 16:17 CET. Details in the imprint.
CME Group Inc. (US12572Q1058) received an analyst upgrade that puts renewed attention on the exchange operator. Keefe, Bruyette & Woods raised its rating to Outperform while maintaining a $305 price target, according to an update dated 06/18/2026.
All news and analysis on CME Group stock
Stay on top of analyst updates, earnings reports and regulatory developments around CME Group with our continuously updated topic overview.
What the analyst upgrade says
On 06/18/2026, Keefe, Bruyette & Woods moved CME Group from Market Perform to Outperform and reiterated a $305 price target, highlighting a positive outlook despite recent share weakness. A GuruFocus summary of the KBW note emphasizes that the broker sees current worries about competition and regulation as overstated.
According to that report, analyst Chris Allen argues that CME’s valuation has become more attractive after a roughly 20% three-month share-price decline and that the company’s franchise remains structurally strong in key derivatives markets. The unchanged $305 target implies notable upside from recent trading levels.
Weekly picture and sector context
Over the past three months, CME Group shares have fallen around 19.8%, leaving the stock near a 52-week low of about $244.56, according to a recent Zacks analysis. The Zacks report notes that this decline is steeper than the broader industry’s near-10% drop over the same period.
Market commentary has pointed to two main overhangs: leadership transition headlines and an intensifying regulatory debate over crypto perpetual futures that could reshape competitive dynamics. At the same time, CME continues to benefit from its position as a key venue for interest-rate, equity-index, FX and commodity derivatives trading, which often sees higher volumes in volatile weeks.
How the company makes money
CME Group generates most of its revenue from transaction and clearing fees on futures and options across asset classes, including benchmark contracts such as E-mini S&P 500 futures, Eurodollar and SOFR interest-rate futures, WTI crude oil futures and agricultural products like corn and wheat.
Where the stock trades today
CME Group Inc. (US12572Q1058) shares trade on the Nasdaq at $246.38 as of 06/18/2026, 16:00 ET.
Key facts on CME Group stock
- Company: CME Group Inc.
- ISIN: US12572Q1058
- WKN: A0MW32
- Ticker: CME
- Venue: Nasdaq
- Price (as of 06/18/2026, 16:00 ET): 246.38 USD
- Market cap: 88.7 billion USD (as of 06/18/2026)
- Sector / Industry: Financials / Financial Exchanges & Data
- Index membership: S&P 500
- Next earnings date: 07/24/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
